• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

CLINICAL FOCUS COLLECTION: Obesity

Video

Obesity, a complex chronic disease in itself, underlies many of the fatal cardiac and cardiometabolic diseases of the 21st century. Find a wide collection of expert guidance in this collection.

Clinical Focus Collection: Obesity and Comorbidities

Table of Contents

Videos – Expert Interviews

The Obesity Paradox: When is it Real? 

Carl J Lavie, MD
Medical Director, Cardiac Rehabilitation and Preventive Cardiology
Ochsner Heart and Vascular Clinic
New Orleans, LA

________________________________________

Pharmacotherapy for Obesity Should Begin in Primary Care

Louis J Aronne, MD
Sanford I Weill Professor of Metabolic Research
Medical Director, Center for Weight Management & Metabolic Research
Weill-Cornell Medical College
New York, NY

________________________________________

Bariatric Surgery: Clinician and Patient Barriers to the First Conversation

Gretchen Ames, PhD
Bariatric Surgery and Medicine Program
Mayo Clinic Bariatric Center
Jacksonville, FL

________________________________________

Obesity Could Stymie Preventive Cardiology Efforts

Ted Kyle, RPh, MBA
Founder, ConscienHealth
Board of Directors, Obesity Action Coalition
Pittsburgh, PA

________________________________________

Diet and Exercise Will Not Sustain Weight Loss in Obesity

Why Roux-en-Y Gastric Bypass Remains the Gold Standard in Bariatric Surgery

Adipose Tissue as an Endocrine Organ and its Role in Obesity

Waning Immunity in the Obese a Risk Factor for COVID-19

Caroline M Apovian, MD
Professor of Medicine and Pediatrics
Section of Endocrinology, Diabetes, Nutrition and Weight Management
Boston University School of Medicine
Boston, MA

________________________________________

Obesity and COVID-19: Very Dangerous Together

Adipose Tissue in Obesity Linked to Prothrombotic State

Experts Anticipate Second-generation Weight-loss Drugs

Opening the Obesity Conversation in Primary Care

Donna Ryan, MD
Professor Emerita
Pennington Biomedical Research Center
Louisiana State University
Baton Rouge, LA



Tests of Clinical Guideline Knowledge

Guideline-directed Weight Loss: 4 Questions for Primary Care Physicians

AHA Guidelines on Obesity for CVD Prevention: 5 Questions

What do you Know about Weight Loss Medications?

4 Questions for PCPs on Prevention and Management of Cardiometabolic Diseases



Slideshows - Education At-a-Glance

New Pledge to Abolish Pernicious Obesity Stigma

International Consensus Condemns Weight Bias

Obesity, Patients, & Physicians: Where do Attitudes Differ?

Why Not Talk About Bariatric Surgery: Why Patients & HCPs Hesitate


More Topics in Obesity and Comorbid Disease

Why is Obesity Medicine the Fastest Growing Medical Specialty in the US?

Bariatric Surgery Shown to Increase Life Expectancy by 3 Years Compared to Usual Care

CDC: Adult Obesity Rising, Racial and Ethnic Disparities Still Exist

Weight Loss in Primary Care Augmented by Liraglutide plus Behavior Therapy

Weight Stigma Predicts Emotional Distress, Binge Eating in Young Adults during COVID-19

Metabolic Effects Comparable with Roux-en-Y vs Diet in Type 2 Diabetes

Obesity in the US: State by State

Bariatric Surgery Yields Therapeutic Hormonal Response

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.